nerve growth factor
nerve growth factor is a pharmaceutical drug with 8 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
Assessment of the Effects of Extensive Somatosensory Training on Pain Processing
Clinical Trials (8)
Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
Assessment of the Effects of Extensive Somatosensory Training on Pain Processing
Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury
Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury
Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8